By offering near unlimited scalability for data storage and processing power, cloud computing is opening a wealth of opportunities in datamining and predictive analytics
By incorporating these innovative tools within Process Analytical Technology (PAT) frameworks, pharmaceutical and biologics manufacturers can boost both process control and quality assurance while streamlining regulatory compliance activities.
Ryan Dougall, Global Sales Manager at Optimal Industrial Technologies, looks at the benefits of adopting cloud-driven PAT frameworks in biopharmaceutical and pharmaceutical production.
PAT is a well-established concept that supports quality driven manufacturing in the pharmaceutical and biopharmaceutical sectors. It provides a dynamic and robust analytical paradigm to control critical process parameters (CPPs) and critical quality attributes (CQAs).
This enables the delivery of consistently and efficiently produced goods that meet the required high levels of quality. The latest technological advances have the potential to enhance the capabilities of PAT frameworks, facilitating next-level real-time process control and quality assurance.
First, the latest analytical instruments and smart sensors allow manufacturers to monitor an increasing number of CPPs with high levels of accuracy and precision.
Secondly, data engineering supports the creation of suitable infrastructures for data capture, sharing and storage. Finally, datamining provides unique methods to generate robust prediction models that link CPPs and CQAs, thus creating an in-depth and holistic understanding of a given process.
By combining these elements together, businesses can further optimise their processes to improve cycle times, raw material and energy utilisation, and to reduce production costs, rejects, reworks and waste.
At the heart of evermore accurate chemometrics models is Big Data analytics. To conduct them, pharmaceutical and biologics manufacturers require high-capacity computing infrastructures.
With mid-infrared process spectrometers now being able to generate multiple spectra every second, the existing on-premise servers and data centres may not have the ability to store, analyse and visualise datasets from multiple devices.
Cloud computing provides a clear solution by offering almost unlimited space for storage and data processing power on demand. This allows manufacturers to set up data-driven process intelligence to enhance their operations and quality control/assurance.
Moreover, the cloud can enhance decentralised data availability to users, which allows them to access information anywhere, anytime and on enterprise-level systems.
As a result, businesses can implement Industrial Internet of Things (IIoT) technologies to create highly automated intelligent factories and smart enterprises.
Pharmaceutical and biologics manufacturers can set up cloud-based centralised platforms for laboratory data, which can accelerate the creation of comprehensive key process knowledge to develop new drugs.
Furthermore, businesses can create a centralised real-time release testing (RTRT) platform to streamline the launch of new products.
It is also possible to manage PAT orchestrations and models (methods) throughout the entire enterprise, establishing uniform procedures across sites that are independent of their geographical location. Therefore, consistency can be substantially enhanced.
Finally, instant reporting capabilities can facilitate and streamline the creation of suitable documentation for quality auditing. To achieve this, it is important for PAT systems to transfer and store data in the cloud while ensuring regulatory compliance.
For example, it is essential that the set-up meets electronic signatures and records (ERES) regulations, including the European Union (EU) GMP (Good Manufacturing Practice) Annex 11 and/or the US Food and Drug Administration (FDA)’s 21 CFR Part 11.
A leading PAT knowledge management platform that supports cloud computing while also meeting regulatory requirements is Optimal’s synTQ. The latest version of the software offers an innovative synTQ-DX data pump function, which allows all synTQ data to be securely transferred to cloud applications and data lakes for analysis as well as reporting.
Any regulatory-compliant datasets transferred to the cloud can also be used to support clinical trials across regulatory review phases and production scale-up.
By implementing such cloud-based technologies, businesses can achieve next-level quality-driven manufacturing. In particular, they can create smart and responsive facilities that deliver medicaments in a time-, cost- and resource-effective way.